GFAP and Alzheimer disease: Reactive astrocyte levels analyzed by GFAP staining were also reduced in the hippocampus and fornix of 3xTg-AD mice receiving iPSC-NPC injection in comparison with PBS-injected animals (Figure 7a–f).